Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022

Published: Mar, 2017 | Pages: 90 | Publisher: RNCOS
Industry: Healthcare | Report Format: Electronic (PDF)

Due to changing lifestyle, a number of disorders like obesity and degenerative joint diseases are affecting the masses across the globe. These factors directly or indirectly develop cartilage injuries; and lead to decline in the productivity of the working population, which ultimately causes some degree of disability. Therefore, increasing epidemiology of such diseases require effective treatment options, generating significant demand for regenerative medicine used to restore damaged cartilage.

According to RNCOS new release, "Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022 ", the industry is expanding at a fast pace. As per RNCOS report, the Cartilage Repair and Regeneration market is anticipated to witness a high double digit growth during the forecasted period (2016-2022). This report provides a detailed analysis of the current and future market scenario of the global Cartilage Repair and Regeneration market. The report provides insight about the major factors affecting growth, latest innovations, market segmentation, and competitive landscape.

The report segments the market on the basis of the treatment modalities, procedure type, applications, and geography, with the future forecasts on all prominent segments of the industry till 2022.

Based on treatment modality, the cell based approaches segment accounts for the largest market share in the overall cartilage repair and regeneration market, due to long-term results of these therapies.

In terms of procedure type, microfracture and ACI are the most common procedure observed amongst all the types of cartilage repair procedure. Furthermore, in terms of application, the hyaline cartilage repair and regeneration market accounts for the largest share in 2016. It is also expected to be the fastest growing application segment in the cartilage repair and regeneration market. The large share and high growth of this segment can be attributed to the high prevalence of cartilage damage in hyaline cartilage.

Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America holds the major share in the market. However, the Asia-Pacific region is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, rising awareness, increasing prevalence of rheumatoid and osteoarthritis, and increasing government initiatives in this region.

The report finally covers the competitive analysis of the key market players, in terms of their market share and their product offerings. The key vendors dominating the market space are Stryker Corp., Zimmer Biomet Holdings Inc., Smith & Nephew Plc, DePuy Synthes, Inc., etc. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player's business model, the player's current and historical financials have been analyzed. Thus, the report provides comprehensive analysis of cartilage repair & regeneration technology, which will enable investors to design suitable business strategies to target this market.

Table of Contents
1. Analyst View
2. Research Methodology
3. Cartilage Repair-Overview
4. Market Dynamics
4.1 Drivers
4.1.1 Growing Incidences of Chondrodystrophies leading to Cartilage Injuries
4.1.2 Rising Incidences of Orthopedic Diseases
4.1.3 Surge in Sports Injuries
4.1.4 Growing Geriatric Popuation
4.1.5 Rising Prevalence of Obesity
4.1.6 Technological Advancements
4.2 Challenges
4.2.1 Limited Health Insurance Coverage in Developing Countries
4.2.2 High Cost of Knee Cartilage Repair Surgeries
4.2.3 Complexity of Cartilage Repair Surgeries
4.3 Opportunities
4.3.1 Significant US Market Opportunity Due to Unsatisfactory First Line Therapies
4.3.2 Emerging Economies to Offer Sustained Growth Opportunities
4.3.3 Increased R&D Spending for Advancements in Knee Cartilage Repair
4.3.4 Use of Bioactive Growth Factors
4.3.5 3D Printing
5. Global Cartilage Repair and Regeneration Market Outlook 2022
6. Cartilage Repair and Regeneration Market, By Treatment Modalities
6.1 Cell-Based Approach
6.2 Non-Cell-Based Approach
7. Global Cartilage Repair and Regeneration Market, By Procedure Type
7.1 Autologous Chondrocyte Transplantation
7.2 Cell-Based Cartilage Resurfacing
7.3 Microfracture
7.4 Osteochondral Allograft
7.5 Others
8. Global Cartilage Repair and Regeneration Market, By Application
8.1 Hyaline Cartilage Repair and Regeneration
8.2 Elastic Cartilage Repair and Regeneration
8.3 Fibrous Cartilage Repair and Regeneration
9. Global Cartilage Repair and Regeneration Market, By Geography
9.1 North America
9.2 Europe
9.3 Asia-Pacific
10. Regulatory Landscape
11. Trends & Developments
11.1 Cost Effectiveness Promoting Interest in One-Step Surgery
11.2 Bioactive Signals that Enhance Cartilage Repair
11.3 Gene Therapy for Cartilage Repair
11.4 Mesenchymal Stem Cells
12. Competitive Landscape
12.1 Market Share of Key Players
12.2 Comparative Analysis of Products
13. Key Players Analysis
13.1 Stryker Corporation
13.2 B. Braun Melsungen AG
13.3 Zimmer Biomet Holdings, Inc.
13.4 Smith & Nephew plc
13.5 DePuy Synthes, Inc. (A Subsidiary of Johnson & Johnson)
13.6 Arthrex, Inc.
13.7 Osiris Therapeutics, Inc.
13.8 Vericel Corporation
13.9 RTI Surgical, Inc.
13.10 CONMED Corporation
13.11 Anika Therapeutics, Inc.
14. The Future of Cartilage Repair

List of Tables:

Table 9-1: North America - Clinical Trials for Cartilage Damage
Table 9-2: Europe - Clinical Trials for Cartilage Damage
Table 9-3: Asia-Pacific - Clinical Trials for Cartilage Damage
Table 12-1: Comparison of Major Cartilage Repair and Regeneration Products
Table 13-1: Stryker Corporation - Key Financials (Million US$), 2014-2016
Table 13-2: Stryker Corporation - Net Sales by Business Segment (Million US$), 2014-2016
Table 13-3: Stryker Corporation - Orthopaedics Net Sales by Product Segment (Million US$), 2014-2016
Table 13-4: Stryker Corporation - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-5: B. Braun Melsungen AG - Key Financials (Million US$), 2013-2015
Table 13-6: B. Braun Melsungen AG - Net Sales by Product Segment (Million US$), 2013-2015
Table 13-7: B. Braun Melsungen AG - Product Portfolio for Cartilage Repair & Regeneration
Table 13-8: Zimmer Biomet Holdings, Inc. - Key Financials (Million US$), 2014-2016
Table 13-9: Zimmer Biomet Holdings, Inc.  - Net Sales by Product Segment (Million US$), 2014-2016
Table 13-10: Zimmer Biomet Holdings, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-11: Smith & Nephew plc - Key Financials (Million US$), 2014-2016
Table 13-12: Smith & Nephew plc - Revenue by Product Segment (Million US$), 2014-2016
Table 13-13: Smith & Nephew plc - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-14: Johnson & Johnson - Key Financials (Million US$), 2013-2015
Table 13-15: Johnson & Johnson - Revenue by Product Segment (Million US$), 2013-2015
Table 13-16: Johnson & Johnson - Medical Devices Revenue by Product Segment (Million US$), 2013-2015
Table 13-17: Johnson & Johnson - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-18: Osiris Therapeutics, Inc. - Key Financials (Million US$), 2012-2014
Table 13-19: Osiris Therapeutics, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-20: Vericel Corporation - Key Financials (Million US$), 2013-2015
Table 13-21: Vericel Corporation - Revenue by Product (Million US$), 2013-2015
Table 13-22: Vericel Corporation - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-23: RTI Surgical, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-24: CONMED Corporation - Key Financials (Million US$), 2013-2015
Table 13-25: CONMED Corporation - Revenue by Product Segment (Million US$), 2013-2015
Table 13-26: CONMED Corporation - Product Portfolio for Cartilage Repair & Regeneration Market
Table 13-27: Anika Therapeutics, Inc. - Key Financials (Million US$), 2013-2015
Table 13-28: Anika Therapeutics, Inc. - Revenue by Product Segment (Million US$), 2013-2015
Table 13-29: Anika Therapeutics, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market